BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9869502)

  • 1. Pharmacologic preconditioning induced by beta-adrenergic stimulation is mediated by activation of protein kinase C.
    Yabe K; Ishishita H; Tanonaka K; Takeo S
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):962-8. PubMed ID: 9869502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
    Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
    J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts.
    Nasa Y; Yabe K; Takeo S
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):436-43. PubMed ID: 9156351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning.
    Khaliulin I; Parker JE; Halestrap AP
    Cardiovasc Res; 2010 Nov; 88(2):324-33. PubMed ID: 20558443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning.
    Robinet A; Hoizey G; Millart H
    Cardiovasc Res; 2005 Jun; 66(3):530-42. PubMed ID: 15914118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat.
    Tanno M; Tsuchida A; Nozawa Y; Matsumoto T; Hasegawa T; Miura T; Shimamoto K
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):345-52. PubMed ID: 10710117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.
    Miura T; Miura T; Kawamura S; Goto M; Sakamoto J; Tsuchida A; Matsuzaki M; Shimamoto K
    Cardiovasc Res; 1998 Mar; 37(3):700-9. PubMed ID: 9659454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A(1) receptor mediates late preconditioning via activation of PKC-delta signaling pathway.
    Kudo M; Wang Y; Xu M; Ayub A; Ashraf M
    Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H296-301. PubMed ID: 12063302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role of PKC in the improvement of energy metabolism in preconditioned heart.
    Yabe K; Tanonaka K; Koshimizu M; Katsuno T; Takeo S
    Basic Res Cardiol; 2000 Jun; 95(3):215-27. PubMed ID: 10879623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of beta 1- and beta 2-adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfusion.
    Frances C; Nazeyrollas P; Prevost A; Moreau F; Pisani J; Davani S; Kantelip JP; Millart H
    J Cardiovasc Pharmacol; 2003 Mar; 41(3):396-405. PubMed ID: 12605018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoproterenol mimics calcium preconditioning-induced protection against ischemia.
    Miyawaki H; Ashraf M
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H927-36. PubMed ID: 9124457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning does not protect against contractile dysfunction in the presence of residual flow: studies in the isolated, blood-perfused rat heart.
    Cave AC; Silverman AS; Apstein CS
    Circulation; 1997 Nov; 96(9):3087-93. PubMed ID: 9386179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C activation and cardioprotective effect of preconditioning with oxidative stress in isolated rat heart.
    Sharma A; Singh M
    Mol Cell Biochem; 2001 Mar; 219(1-2):1-6. PubMed ID: 11354240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.
    Salie R; Moolman JA; Lochner A
    Basic Res Cardiol; 2012 Sep; 107(5):281. PubMed ID: 22797560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning.
    Ping P; Takano H; Zhang J; Tang XL; Qiu Y; Li RC; Banerjee S; Dawn B; Balafonova Z; Bolli R
    Circ Res; 1999 Mar; 84(5):587-604. PubMed ID: 10082480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic preconditioning promotes a transient, but not sustained translocation of protein kinase C and sensitization of adenylyl cyclase.
    Simonis G; Weinbrenner C; Strasser RH
    Basic Res Cardiol; 2003 Mar; 98(2):104-13. PubMed ID: 12607132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits.
    Miki T; Cohen MV; Downey JM
    Mol Cell Biochem; 1998 Sep; 186(1-2):3-12. PubMed ID: 9774179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC).
    Salie R; Moolman JA; Lochner A
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging abolishes the cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts.
    Honma Y; Tani M; Takayama M; Yamamura K; Hasegawa H
    Basic Res Cardiol; 2002 Nov; 97(6):489-95. PubMed ID: 12395211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.